Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Skye Bioscience (SKYE)
NASDAQ:SKYE
Skye Bioscience (SKYE) Stock Price & Analysis
134 Followers
SKYE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $19.41
Previous Close$6.44
Volume214.77K
Average Volume (3M)208.80K
Market Cap
$180.76M
Enterprise Value$184.12M
Total Cash (Recent Filing)$1.26M
Total Debt (Recent Filing)$4.62M
Price to Earnings (P/E)―
Beta0.67
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.50
Shares Outstanding28,067,907
10 Day Avg. Volume457,491
30 Day Avg. Volume208,804
Standard Deviation0.47
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.09
Forecast
1Y Price Target
$20.00Price Target Upside217.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Skye Bioscience News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SKYE FAQ
What was Skye Bioscience’s price range in the past 12 months?
Skye Bioscience lowest stock price was <$0.01 and its highest was $19.41 in the past 12 months.
What is Skye Bioscience’s market cap?
Currently, no data Available
When is Skye Bioscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Skye Bioscience’s earnings last quarter?
Currently, no data Available
Is Skye Bioscience overvalued?
According to Wall Street analysts Skye Bioscience’s price is currently Undervalued.
Does Skye Bioscience pay dividends?
Skye Bioscience does not currently pay dividends.
What is Skye Bioscience’s EPS estimate?
Skye Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Skye Bioscience have?
Skye Bioscience has 28,067,907 shares outstanding.
What happened to Skye Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Skye Bioscience?
Among the largest hedge funds holding Skye Bioscience’s share is Versant Venture Management, LLC. It holds Skye Bioscience’s shares valued at 31M.
---
Skye Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.00 (217.46% Upside)
$20.00 (217.46% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 6.3%
Last 30 Days ▲ 6.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30566.66%
12-Months-Change
Fundamentals
Return on Equity
-101.20%
Trailing 12-Months
Asset Growth
1967.51%
Trailing 12-Months
Company Description
Skye Bioscience
Emerald Bioscience, Inc. engages on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. The company was founded on March 16, 2011 and is headquartered in Long Beach, CA.
---
SKYE Stock 12 Month Forecast
Average Price Target
$20.00
▲(217.46% Upside)
Technical Analysis
Best Analysts Covering SKYE
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-2.35%
reiterated a buy rating 4 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -2.35% per trade.
---